Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings.

BACKGROUND Genetic disorders and congenital anomalies are the leading causes of infant mortality. Diagnosis of most genetic diseases in neonatal and paediatric intensive care units (NICU and PICU) is not sufficiently timely to guide acute clinical management. We used rapid whole-genome sequencing (STATseq) in a level 4 NICU and PICU to assess the rate and types of molecular diagnoses, and the prevalence, types, and effect of diagnoses that are likely to change medical management in critically ill infants. METHODS We did a retrospective comparison of STATseq and standard genetic testing in a case series from the NICU and PICU of a large children's hospital between Nov 11, 2011, and Oct 1, 2014. The participants were families with an infant younger than 4 months with an acute illness of suspected genetic cause. The intervention was STATseq of trios (both parents and their affected infant). The main measures were the diagnostic rate, time to diagnosis, and rate of change in management after standard genetic testing and STATseq. FINDINGS 20 (57%) of 35 infants were diagnosed with a genetic disease by use of STATseq and three (9%) of 32 by use of standard genetic testing (p=0·0002). Median time to genome analysis was 5 days (range 3-153) and median time to STATseq report was 23 days (5-912). 13 (65%) of 20 STATseq diagnoses were associated with de-novo mutations. Acute clinical usefulness was noted in 13 (65%) of 20 infants with a STATseq diagnosis, four (20%) had diagnoses with strongly favourable effects on management, and six (30%) were started on palliative care. 120-day mortality was 57% (12 of 21) in infants with a genetic diagnosis. INTERPRETATION In selected acutely ill infants, STATseq had a high rate of diagnosis of genetic disorders. Most diagnoses altered the management of infants in the NICU or PICU. The very high infant mortality rate indicates a substantial need for rapid genomic diagnoses to be allied with a novel framework for precision medicine for infants in NICU and PICU who are diagnosed with genetic diseases to improve outcomes. FUNDING Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Human Genome Research Institute, and National Center for Advancing Translational Sciences.

[1]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[2]  Marcel H. Schulz,et al.  Clinical diagnostics in human genetics with semantic similarity searches in ontologies. , 2009, American journal of human genetics.

[3]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[4]  M J Khoury,et al.  Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. , 1997, Archives of pediatrics & adolescent medicine.

[5]  Laurie D. Smith,et al.  Exome Sequencing Reveals De Novo Germline Mutation of the Mammalian Target of Rapamycin (MTOR) in a Patient with Megalencephaly and Intractable Seizures , 2013 .

[6]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[7]  Eric Vilain,et al.  Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.

[8]  J. Lupski,et al.  Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy , 2013, Genome Medicine.

[9]  T. Hansen,et al.  Deaths in a neonatal intensive care unit: A 10-year perspective , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[10]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[11]  J. Lupski,et al.  Human genome sequencing in health and disease. , 2012, Annual review of medicine.

[12]  Xuan Yuan,et al.  Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders , 2014, Science Translational Medicine.

[13]  K. Kurosawa,et al.  Proportion of malformations and genetic disorders among cases encountered at a high-care unit in a children’s hospital , 2012, European Journal of Pediatrics.

[14]  G. Downing,et al.  Enhancing the quality and efficiency of newborn screening programs through the use of health information technology. , 2010, Seminars in perinatology.

[15]  J. Lantos,et al.  How infants die in the neonatal intensive care unit: trends from 1999 through 2008. , 2011, Archives of pediatrics & adolescent medicine.

[16]  Vineet Bafna,et al.  Exome Sequencing Can Improve Diagnosis and Alter Patient Management , 2012, Science Translational Medicine.

[17]  Masaki Aono,et al.  Estimating a ranked list of human hereditary diseases for clinical phenotypes by using weighted bipartite network , 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[18]  J. Carey,et al.  Contribution of malformations and genetic disorders to mortality in a children's hospital , 2004, American journal of medical genetics. Part A.

[19]  T. Berger,et al.  Causes and Circumstances of Neonatal Deaths in 108 Consecutive Cases over a 10-Year Period at the Children’s Hospital of Lucerne, Switzerland , 2008, Neonatology.

[20]  M. Edwards,et al.  New Approaches to Prevent LEOPARD Syndrome-associated Cardiac Hypertrophy by Specifically Targeting Shp2-dependent Signaling* , 2013, The Journal of Biological Chemistry.

[21]  Soma Das,et al.  Technical Standards and Guidelines: Molecular Genetic Testing for Ultra-Rare Disorders , 2005, Genetics in Medicine.

[22]  J. Lupski,et al.  Clan Genomics and the Complex Architecture of Human Disease , 2011, Cell.

[23]  R. Hutcheon,et al.  Genetic disorders and congenital malformations in pediatric long-term care. , 2007, Journal of the American Medical Directors Association.

[24]  Damian Smedley,et al.  Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome , 2014, Science Translational Medicine.

[25]  M. Guyer,et al.  Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.

[26]  J. Lantos,et al.  Costs and End-of-Life Care in the NICU: Lessons for the MICU? , 2011, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[27]  J. Lawn,et al.  Preterm Birth: Now the Leading Cause of Child Death Worldwide , 2014, Science Translational Medicine.

[28]  David R. Murdock,et al.  Whole-Genome Sequencing for Optimized Patient Management , 2011, Science Translational Medicine.

[29]  Neil A. Miller,et al.  Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing , 2011, Expert review of molecular diagnostics.

[30]  Kelly Schoch,et al.  Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.

[31]  A. Pérez-Muñuzuri,et al.  Inborn errors of metabolism in a neonatology unit: Impact and long‐term results , 2011, Pediatrics international : official journal of the Japan Pediatric Society.

[32]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[33]  Peter Saffrey,et al.  Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units , 2012, Science Translational Medicine.

[34]  Laurie D. Smith,et al.  A systematic Approach to Implementing Monogenic Genomic Medicine: Genotype-Driven Diagnosis of Genetic Diseases , 2012 .

[35]  H. Pinar.  Postmortem findings in term neonates. , 2004, Seminars in neonatology : SN.

[36]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[37]  S. Curtin,et al.  Births: final data for 2012. , 2013, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[38]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[39]  Allyn McConkie-Rosell,et al.  The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders , 2013, Genetics in Medicine.

[40]  Xiang Li,et al.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.

[41]  S. Kingsmore,et al.  Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? , 2011, Science Translational Medicine.

[42]  Siddharth Srivastava,et al.  Clinical whole exome sequencing in child neurology practice , 2014, Annals of neurology.

[43]  Wilko Spiering,et al.  Diagnostic Clinical Genome and Exome Sequencing , 2014 .

[44]  P. Stankiewicz,et al.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.

[45]  B. Neel,et al.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. , 2011, The Journal of clinical investigation.

[46]  A. StAteMent.  Points to consider in the clinical application of genomic sequencing , 2012, Genetics in Medicine.

[47]  P. Loughnan,et al.  Death in the neonatal intensive care unit: changing patterns of end of life care over two decades , 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[48]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[49]  J. Ray,et al.  Maternal and neonatal separation and mortality associated with concurrent admissions to intensive care units , 2012, Canadian Medical Association Journal.

[50]  Sebastian Köhler,et al.  Ontological phenotype standards for neurogenetics , 2012, Human mutation.

[51]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[52]  Laurie D. Smith,et al.  N-of-1 genomic medicine for the rare pediatric genetic diseases , 2014 .

[53]  David P Bick,et al.  Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.

[54]  H. Jacob.  Genetic diagnosis through whole-exome sequencing. , 2014, The New England journal of medicine.